Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11823375 | 1.00 | TSHR (0.49) | TSHRGAAKDM4ENPC1RAB9A | |
| Hydrochloric Acid SCHEMBL11826513 | 0.99 | TSHR (0.48) | TSHRGAAKDM4ENPC1RAB9A | |
| SCHEMBL29358295 | 0.84 | KDM4E (0.52) | TSHRGAAKDM4EALDH1A1LMNA | |
| SCHEMBL30485743 | 0.82 | ALDH1A1 (0.52) | TSHRGAAKDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL19124093 | 0.79 | TSHR (0.57) | TSHRGAAKDM4ENPC1RAB9A | |
| SCHEMBL9172859 | 0.75 | LMNA (0.58) | GAAKDM4EALDH1A1LMNAKMT2A | |
| SCHEMBL5575328 | 0.75 | GAA (0.78) | TSHRGAAKDM4ENPC1RAB9A | |
| SCHEMBL11827857 | 0.75 | GAA (0.64) | TSHRGAAKDM4ENPC1RAB9A | |
| SCHEMBL29833947 | 0.74 | CNR1 (0.47) | TSHRGAAALDH1A1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL11035003 | 0.74 | LMNA (0.57) | TSHRGAAKDM4EALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4376952-A1 | ANTI-SIRP-ALPHA ANTIBODIES AND METHODS OF USE THEREOF | Alector LLC (US) | 2024-06-05 | — | — | EP | claimed |
| CN-114259469-B | Sialic acid assisted delivery pharmaceutical composition capable of reversing tumor-related immunosenescence and preparation method and application thereof | 沈阳药科大学 | 2023-02-21 | — | — | CN | claimed |
| WO-2023010076-A1 | ANTI-SIRP-ALPHA ANTIBODIES AND METHODS OF USE THEREOF | ALECTOR LLC (US) | 2023-02-02 | — | — | WO | claimed |
| CN-111973570-B | Sialic acid derivative modified ibrutinib nano-composite and preparation method thereof | 沈阳药科大学 | 2022-11-25 | — | — | CN | claimed |
| CN-114259469-A | Sialic acid assisted delivery pharmaceutical composition capable of reversing tumor-related immunosenescence and preparation method and application thereof | 沈阳药科大学 | 2022-04-01 | — | — | CN | claimed |
| US-12624290-B2 | Method for reducing white flicker | MERCK PATENT GMBH (DE) | 2026-05-12 | — | — | US | disclosed |
| US-12618007-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-05-05 | — | — | US | disclosed |
| US-20260116911-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SAGE THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260116912-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SAGE THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4733370-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-12560413-B2 | Device, system, and method of aircraft protection and countermeasures against missiles | BIRD AEROSYSTEMS LTD. (IL) | 2026-02-24 | — | — | US | disclosed |
| US-12552991-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-02-17 | — | — | US | disclosed |
| US-20220112426-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2022-04-14 | — | — | US | disclosed |
| EP-3978575-A1 | ANTIFOULING COATING COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2022-04-06 | — | — | EP | disclosed |
| CN-114259469-A | Sialic acid assisted delivery pharmaceutical composition capable of reversing tumor-related immunosenescence and preparation method and application thereof | 沈阳药科大学 | 2022-04-01 | — | — | CN | disclosed |
| CN-114269863-A | Antifouling coating composition | 日东化成株式会社 | 2022-04-01 | — | — | CN | disclosed |
| CN-110577557-B | Sialic acid lipid derivative and preparation method and application thereof | 沈阳药科大学 | 2022-03-11 | — | — | CN | disclosed |
| US-11261211-B2 | 19-NOR neuroactive steroids and methods of use thereof | SAGE THERAPEUTICS, INC. (US) | 2022-03-01 | — | — | US | disclosed |
| US-11254872-B2 | Liquid crystal media comprising polymerisable compounds | MERCK PATENT GMBH (DE) | 2022-02-22 | — | — | US | disclosed |
| CN-111057672-B | Recombinant strain and application thereof | 宜昌东阳光生化制药有限公司 | 2022-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552991-B2 | Liquid-crystalline medium | FES, VIM, INHA | TSHR 221/4885GAA 3771/4885KDM4E 2896/4885 |
| US-12618007-B2 | Liquid-crystalline medium | SOST, NES, VIM | TSHR 174/4885GAA 2472/4885KDM4E 4175/4885 |
| US-20260116912-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SCN4A, CHRNA4, CACNG4 | TSHR 764/4885GAA 4764/4885KDM4E 1481/4885 |
| US-20260116911-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SCN4A, CACNG4, SLC6A4 | TSHR 810/4885GAA 4679/4885KDM4E 1522/4885 |
| US-12624290-B2 | Method for reducing white flicker | HCN4, HCN2, HCN3 | TSHR 2060/4885GAA 4869/4885KDM4E 2158/4885 |
| US-11261211-B2 | 19-NOR neuroactive steroids and methods of use thereof | NR3C2, HSD3B1, NR3C1 | TSHR 856/4885GAA 3951/4885KDM4E 3171/4885 |
| US-12560413-B2 | Device, system, and method of aircraft protection and countermeasures against missiles | MRE11, SAMM50, LBR | TSHR 854/4885GAA 3825/4885KDM4E 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.